Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prophylactic Cranial Irradiation Reduces Brain Metastases and Improves Overall Survival in High-Risk Metastatic Non-Small Cell Lung Cancer Patients: A Randomized phase 2 Study (PRoT-BM trial).
Arrieta O, Maldonado F, Turcott JG, Zatarain-Barrón ZL, Barrón F, Blake-Cerda M, Cabrera-Miranda LA, Cardona AF, de la Garza JG, Rosell R. Arrieta O, et al. Among authors: cabrera miranda la. Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1442-1450. doi: 10.1016/j.ijrobp.2021.02.044. Epub 2021 Feb 25. Int J Radiat Oncol Biol Phys. 2021. PMID: 33640422 Clinical Trial.
Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non-small cell lung cancer.
Arrieta O, Aviles-Salas A, Orozco-Morales M, Hernández-Pedro N, Cardona AF, Cabrera-Miranda L, Barrios-Bernal P, Soca-Chafre G, Cruz-Rico G, Peña-Torres ML, Moncada-Claudio G, Ramirez-Tirado LA. Arrieta O, et al. Cancer Med. 2020 Apr;9(7):2390-2402. doi: 10.1002/cam4.2882. Epub 2020 Feb 11. Cancer Med. 2020. PMID: 32043750 Free PMC article.
Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 study.
Blake-Cerda M, Lozano-Ruíz F, Maldonado-Magos F, de la Mata-Moya D, Díaz-García D, Lara-Mejía L, Zatarain-Barrón ZL, Cuevas-Góngora MF, Barron-Barron F, Corona-Cruz JF, Cabrera-Miranda L, Arroyo-Hernández M, Gerson R, Arrieta O. Blake-Cerda M, et al. Lung Cancer. 2021 Feb;152:119-126. doi: 10.1016/j.lungcan.2020.12.029. Epub 2020 Dec 28. Lung Cancer. 2021. PMID: 33385737 Clinical Trial.
Prophylactic Cranial Irradiation in Patients With High-Risk Metastatic Non-Small Cell Lung Cancer: Quality of Life and Neurocognitive Analysis of a Randomized Phase II Study.
Maldonado F, Gonzalez-Ling A, Oñate-Ocaña LF, Cabrera-Miranda LA, Zatarain-Barrón ZL, Turcott JG, Flores-Estrada D, Lozano-Ruiz F, Cacho-Díaz B, Arrieta O. Maldonado F, et al. Among authors: cabrera miranda la. Int J Radiat Oncol Biol Phys. 2021 Sep 1;111(1):81-92. doi: 10.1016/j.ijrobp.2021.04.017. Epub 2021 Apr 26. Int J Radiat Oncol Biol Phys. 2021. PMID: 33915217 Clinical Trial.
Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung Cancer.
Arrieta O, Varela-Santoyo E, Cardona AF, Sánchez-Reyes R, Lara-Mejía L, Bassarmal SS, Valle-Bautista D, Corrales-Rodríguez L, Motola-Kuba D, Cabrera-Miranda L, Martín C. Arrieta O, et al. Clin Lung Cancer. 2021 Nov;22(6):510-522. doi: 10.1016/j.cllc.2021.03.014. Epub 2021 Mar 27. Clin Lung Cancer. 2021. PMID: 33947631
Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma.
Arrieta O, Muñoz-Montaño W, Muñiz-Hernández S, Campos S, Catalán R, Soto-Molina H, Guzmán Vázquez S, Díaz-Álvarez O, Martínez-Pacheco V, Turcott JG, Ramos-Ramírez M, Cabrera-Miranda L, Barrón F, Cardona AF. Arrieta O, et al. Front Oncol. 2021 Apr 20;11:641975. doi: 10.3389/fonc.2021.641975. eCollection 2021. Front Oncol. 2021. PMID: 33959504 Free PMC article.
Association of Lung Adenocarcinoma Subtypes According to the IASLC/ATS/ERS Classification and Programmed Cell Death Ligand 1 (PD-L1) Expression in Tumor Cells.
Cruz-Rico G, Avilés-Salas A, Popa-Navarro X, Lara-Mejía L, Catalán R, Sánchez-Reyes R, López-Sánchez D, Cabrera-Miranda L, Aquiles Maldonado-Martínez H, Samtani-Bassarmal S, Arrieta O. Cruz-Rico G, et al. Pathol Oncol Res. 2021 Apr 8;27:597499. doi: 10.3389/pore.2021.597499. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34257548 Free PMC article.
Clinical Impact of the COVID-19 Pandemic in Mexican Patients with Thoracic Malignancies.
Arrieta O, Lara-Mejía L, Bautista-GonzÁlez E, Heredia D, Turcott JG, BarrÓn F, Ramos-Ramírez M, Cabrera-Miranda L, Salinas Padilla MÁ, Aguerrebere M, Cardona AF, Rolfo C, Arroyo-HernÁndez M, Soto-Pérez-de-Celis E, Baéz-Saldaña R. Arrieta O, et al. Oncologist. 2021 Dec;26(12):1035-1043. doi: 10.1002/onco.13962. Epub 2021 Sep 9. Oncologist. 2021. PMID: 34498780 Free PMC article.
13 results